docarpamine

Known as: N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine, do carpamine 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1990-2013
01219902013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
The heart failure guideline in Japan has stated the necessity of investigating the role of oral inotropic agents in patients with… (More)
Is this relevant?
2006
2006
BACKGROUND Salt-sensitive (SS) hypertension affects >30 million Americans and is often associated with low plasma renin activity… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2003
2003
Dopamine treatment constitutes a major advance towards the management of severe ovarian hyperstimulation syndrome (OHSS) by… (More)
Is this relevant?
2000
2000
We studied the effects of bolus intravenous injection of the dopamine prodrug, docarpamine (200 microg/kg), on mean arterial… (More)
Is this relevant?
2000
2000
Docarpamine is a dopamine prodrug which has been selected from a large number of dopamine derivatives in order to develop an… (More)
Is this relevant?
1999
1999
OBJECTIVE:Refractory ascites is a debilitating condition in patients with cirrhosis. Recently, docarpamine, an orally active… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Review
1999
Review
1999
BACKGROUND Docarpamine (DOC) is a dopamine prodrug which can be orally administered. It has been found that oral docarpamine… (More)
Is this relevant?
1997
1997
To evaluate the clinical efficacy of orally active dopamine prodrug, docarpamine [N-(N-acetyl-L-methionyl)-O,O-bis… (More)
Is this relevant?
1995
1995
Docarpamine is a dopamine prodrug which has been selected from a large number of dopamine derivatives in order to develop an… (More)
Is this relevant?
1991
1991
Positive inotropic and renal vasodilatory effects of a novel dopamine prodrug, docarpamine, [N-(N-acetyl-L-methionyl)-3,4-bis… (More)
Is this relevant?